Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Biometrics. 2023 Aug 8;79(4):3624–3636. doi: 10.1111/biom.13918

Table 5:

ATE estimates of lung function in the CF study from the proposed BNP method. The lung function outcome measures are processed using varying time windows, i.e., measurements at 6 months plus/minus a time window and 12 months plus/minus a time window. The ATE estimate, its standard error, the 95% credible interval, and the posterior probability that the ATE is greater than zero are presented for different measurements with varying time windows.

Time window Estimand Est SE 95% CI P(ATE >0)

1 week ATE at 6 month 6.04 2.37 (1.36, 10.72) 0.994
ATE at 12 month 2.71 1.98 (−1.24, 6.45) 0.908
2 weeks ATE at 6 month 2.90 1.79 (−0.61, 6.39) 0.946
ATE at 12 month −0.68 1.66 (−4.00, 2.58) 0.341
1 month ATE at 6 month 1.51 1.44 (−1.36, 4.28) 0.852
ATE at 12 month 1.77 1.34 (−0.85, 4.40) 0.906
1.5 months ATE at 6 month 0.66 1.24 (−1.76, 3.09) 0.705
ATE at 12 month 0.95 1.21 (−1.42, 3.37) 0.787